Abstract:In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. In recent years, the most common pharmacological treatment for Alzheimer's disease (AD) has been acetylcholinesterase (AChE) inhibition. However, this single-target approach has limited effectiveness and there is evidence that a multitarget approach might be more effective. Huperzine A (HupA), a novel alkaloid isolated from a Chinese herb, has neuroprotective effects that go beyond the inhibition of AChE. Recent data have demonstrated that HupA can ameliorate the learning and memory deficiency in animal models and AD patients. Its potentially beneficial actions include modification of β-amyloid peptide processing, reduction of oxidative stress, neuronal protection against apoptosis, and regulation of the expression and secretion of nerve growth factor (NGF) and NGF signaling. an enzyme found in most plant and animal cells that functions as an oxidative catalyst. It decomposes hydrogen peroxide into hydrogen and water. a series of enzymatic reactions in aerobic organisms involving oxidative metabolism of acetyl units and producing high-energy phosphate compounds, which serve as the main source of cellular energy. optically rotating to the right. The rotation of interest in chemistry is induced by a chiral molecule. The direction of rotation cannot be predicted from the R or S designation of the configuration at the stereocenter: in some cases the R isomer is dextrorotatory and the S isomer is levorotatory, whereas in other cases it is the other way around. an enzyme in the body that is a powerful scavenger of free radicals; it helps to prevent peroxidation of cell membranes by consuming free peroxide in the cell. optically rotating to the left. The levorotatory isomer of optically active compounds is the form usually found in nature. a by-product of lipid metabolism in the body. It is also found in many foods and can be present in high amounts in rancid food. an enzyme that catalyzes the decomposition of a superoxide into hydrogen peroxide and oxygen. a transgenic mouse strain that overexpresses a mutant form of human amyloid precursor protein with the Swedish mutation (APPSw), resulting in high Aβ levels in the brain. a dementia that is caused by disease of the blood vessels of the brain (cerebrovascular disease). It is the second most common form of dementia after AD.

A Novel Peroxidase Mimics And Ameliorates Alzheimer'S Disease-Related Pathology And Cognitive Decline In Mice

A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-β-Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence Through Upregulating SIRT3.

A New Chiral Pyrrolyl Alpha-Nitronyl Nitroxide Radical Attenuates Beta-Amyloid Deposition And Rescues Memory Deficits In A Mouse Model Of Alzheimer Disease

A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease

A Deuterohemin Peptide Protects a Transgenic Caenorhabditis Elegans Model of Alzheimer’s Disease by Inhibiting Aβ1–42 Aggregation

Extending Lifespan of Alzheimer’s Mode Nematode CL4176 Using a Novel Bifunctional Peptide with Inhibition of Β -Amyloid Aggregation and Anti-oxidation

β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling

Inhibiting Aβ Toxicity in Alzheimer's Disease by a Pyridine Amine Derivative.

DHPA Protects SH-SY5Y Cells from Oxidative Stress-Induced Apoptosis via Mitochondria Apoptosis and the Keap1/Nrf2/HO-1 Signaling Pathway

A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease

Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer’s Disease

A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice

Long-term oral administration of hyperoside ameliorates AD-related neuropathology and improves cognitive impairment in APP/PS1 transgenic mice

Glutathione-mimetic D609 alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

S14G-Humanin Improves Cognitive Deficits and Reduces Amyloid Pathology in the Middle-Aged APPswe/PS1dE9 Mice

Inhibition of Aβ Aggregation and Tau Phosphorylation with Functionalized Biomimetic Nanoparticles for Synergic Alzheimer’s Disease Therapy

Potassium 2-(1-Hydroxypentyl)-Benzoate Improves Memory Deficits and Attenuates Amyloid and τ Pathologies in a Mouse Model of Alzheimer's Disease

A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.

The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice

DHMBA, a Molecule from Pacific Oyster (crassostrea Gigas)alleviates AD Pathology by Inhibiting Ubiquination of Nrf2

Neuroprotective Effects of Huperzine A: New Therapeutic Targets for Neurodegenerative Disease